Allworth Financial LP Decreases Holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Allworth Financial LP trimmed its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 7.7% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 18,244 shares of the pharmacy operator’s stock after selling 1,524 shares during the period. Allworth Financial LP’s holdings in Walgreens Boots Alliance were worth $170,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other institutional investors also recently bought and sold shares of WBA. First Financial Corp IN lifted its holdings in Walgreens Boots Alliance by 49.2% during the 4th quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after buying an additional 885 shares during the last quarter. Golden State Wealth Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the 4th quarter valued at about $26,000. TD Private Client Wealth LLC lifted its holdings in shares of Walgreens Boots Alliance by 8,670.3% in the 3rd quarter. TD Private Client Wealth LLC now owns 3,245 shares of the pharmacy operator’s stock valued at $29,000 after purchasing an additional 3,208 shares during the last quarter. Sentry Investment Management LLC purchased a new stake in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $30,000. Finally, Eastern Bank purchased a new stake in shares of Walgreens Boots Alliance in the 3rd quarter valued at about $33,000. 58.59% of the stock is owned by hedge funds and other institutional investors.

Walgreens Boots Alliance Stock Performance

Shares of WBA stock opened at $10.16 on Friday. The company has a quick ratio of 0.30, a current ratio of 0.64 and a debt-to-equity ratio of 0.68. The stock’s 50-day moving average price is $10.37 and its 200 day moving average price is $9.70. Walgreens Boots Alliance, Inc. has a 52-week low of $8.08 and a 52-week high of $22.05. The stock has a market capitalization of $8.78 billion, a PE ratio of -0.99, a price-to-earnings-growth ratio of 1.31 and a beta of 0.65.

Walgreens Boots Alliance (NASDAQ:WBA) last released its earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.38 by $0.13. Walgreens Boots Alliance had a positive return on equity of 17.61% and a negative net margin of 5.87%. The company had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. During the same quarter in the previous year, the firm posted $0.66 EPS. The firm’s quarterly revenue was up 7.6% on a year-over-year basis. As a group, equities research analysts forecast that Walgreens Boots Alliance, Inc. will post 1.6 EPS for the current year.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on WBA shares. Bank of America boosted their target price on Walgreens Boots Alliance from $7.50 to $8.50 and gave the company an “underperform” rating in a report on Monday, January 13th. Evercore ISI boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company an “in-line” rating in a report on Monday, January 13th. Royal Bank of Canada boosted their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. Finally, Truist Financial reduced their target price on Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating for the company in a report on Friday, January 31st. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $12.63.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.